000 05989nam a22005175i 4500
001 978-1-4614-2012-5
003 DE-He213
005 20140220083244.0
007 cr nn 008mamaa
008 120302s2012 xxu| s |||| 0|eng d
020 _a9781461420125
_9978-1-4614-2012-5
024 7 _a10.1007/978-1-4614-2012-5
_2doi
050 4 _aRC434.2-574
072 7 _aMMH
_2bicssc
072 7 _aMED105000
_2bisacsh
082 0 4 _a616.89
_223
100 1 _ade Leon, Jose.
_eeditor.
245 1 2 _aA Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
_h[electronic resource] /
_cedited by Jose de Leon.
264 1 _aBoston, MA :
_bSpringer US,
_c2012.
300 _aXXXI, 507p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1. Introduction -- 2. A Practitioner’s Guide to Prescribing Carbamazepine for Adults with Intellectual Disabilities -- 3. A Practitioner’s Guide to Prescribing Clonazepam for Adults with Intellectual Disabilities -- 4. A Practitioner’s Guide to Prescribing Diazepam for Adults with Intellectual Disabilities -- 5. A Practitioner’s Guide to Prescribing Ethosuximide for Adults with Intellectual Disabilities -- 6. A Practitioner’s Guide to Prescribing Felbamate for Adults with Intellectual Disabilities -- 7. A Practitioner’s Guide to Prescribing Gabapentin for Adults with Intellectual Disabilities -- 8. A Practitioner’s Guide to Prescribing Lacosamide for Adults with Intellectual Disabilities -- 9. A Practitioner’s Guide to Prescribing Lamotrigine For Adults with Intellectual Disabilities -- 10. A Practitioner’s Guide to Prescribing Levetiracetam for Adults with Intellectual Disabilities -- 11. A Practitioner’s Guide to Prescribing Lithium for Adults with Intellectual Disabilities -- 12. A Practitioner’s Guide to Prescribing Lorazepam for Adults with Intellectual Disabilities -- 13. A Practitioner’s Guide to Prescribing Oxacarbazepine for Adults with Intellectual Disabilities -- 14. A Practitioner’s Guide to Prescribing Phenobarbital for Adults with Intellectual Disabilities -- 15. A Practitioner’s Guide to Prescribing Phenytoin for Adults with Intellectual Disabilities -- 16. A Practitioner’s Guide to Prescribing Pregabalin for Adults with Intellectual Disabilities -- 17. A Practitioner’s Guide to Prescribing Primidone for Adults with Intellectual Disabilities -- 18. A Practitioner’s Guide to Prescribing Rufinamide for Adults with Intellectual Disabilities -- 19.  A Practitioner’s Guide to Prescribing Tiagabine for Adults with Intellectual Disabilities -- 20. A Practitioner’s Guide to Prescribing Topiramate for Adults with Intellectual Disabilities -- 21. A Practitioner’s Guide to Prescribing Valproate for Adults with Intellectual Disabilities -- 22. A Practitioner’s Guide to Prescribing Zonisamide for Adults with Intellectual Disabilities -- 23. A Practitioner’s Guide to Prescribing Non-oral Antiepileptics for Adults with Intellectual Disabilities -- 24. Conclusion.
520 _aEmotional, behavioral, and neuropsychiatric conditions are common in individuals with intellectual disabilities (IDs), most notably epilepsy, aggression, self-injurious behaviors, and bipolar and other mood disorders. Despite the prevalence of such problems, there is a scarcity in the literature of reliable information on medical treatments for those with IDs. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities provides a detailed framework for prescribing for this challenging population. Featuring the most up-to-date information on factors that inform prescribing, the Guide addresses basic issues and controversies (e.g., the rift between evidence-based and personalized medicine) in treating adults with cognitive deficits. Clients' specific needs are emphasized in developing appropriate and effective pharmacological intervention for improved outcomes and quality of life. Drugs discussed in the Guide include carbamazepine, clonazepam, diazepam, ethosuximide, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, lithium, lorazepam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, primidone, rufinamide,  tiagabine, topiramate, valproate, and zonisamide. For each of these compounds, the guidelines cover: Indications for use; relative and absolute contraindications. Assessment during treatment; therapeutic drug monitoring; warning signs and symptoms for caretakers. Dosage: administration; initial and maximum recommended dosage; modifications associated with drug-drug interactions, personal characteristics, and (where appropriate) genetic variations. Adverse drug reactions: common, relatively uncommon, and potentially lethal, plus risk of metabolic syndrome. Guidelines for discontinuation. References, tables, and drug utilization reviews. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities is an indispensable decision-making reference for psychiatrists, neuropsychologists, psychopharmacologists, neurologists, internists, and clinical psychologists.
650 0 _aMedicine.
650 0 _aInternal medicine.
650 0 _aNeurology.
650 0 _aPsychiatry.
650 0 _aPsychopharmacology.
650 0 _aPsychology, clinical.
650 1 4 _aMedicine & Public Health.
650 2 4 _aPsychiatry.
650 2 4 _aNeuropsychology.
650 2 4 _aPsychopharmacology.
650 2 4 _aNeurology.
650 2 4 _aInternal Medicine.
650 2 4 _aClinical Psychology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461420118
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-2012-5
912 _aZDB-2-SME
999 _c101179
_d101179